Home >> Allergy/Immunology >> Allergy/Immunology >> Baby Food >> Technology & Media >>

Sjogren's Syndrome Global Clinical Trials Review, H2, 2014

Published: Dec-2014 | Format: PDF | GlobalData | Number of pages: 76 | Code: MRS - 3172

Summary

GlobalData's clinical trial report, “Sjogren's Syndrome Global Clinical Trials Review, H2, 2014" provides data on the Sjogren’s Syndrome clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Sjogren’s Syndrome. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Sjogren’s Syndrome. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Sjogren's Syndrome 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Sjogren's Syndrome to Immunology Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Sjogren's Syndrome to Immunology Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Sjogren's Syndrome 25
Subjects Recruited Over a Period of Time 27
Clinical Trials by Sponsor Type 28
Prominent Sponsors 29
Top Companies Participating in Sjogren's Syndrome Therapeutics Clinical Trials 30
Prominent Drugs 31
Clinical Trial Profiles 32
Clinical Trial Overview of Top Companies 32
Novartis AG 32
Clinical Trial Overview of Novartis AG 32
Volution Immuno Pharmaceuticals (VIP) SA 33
Clinical Trial Overview of Volution Immuno Pharmaceuticals (VIP) SA 33
Parion Sciences, Inc. 34
Clinical Trial Overview of Parion Sciences, Inc. 34
Ferring International Center S.A. 35
Clinical Trial Overview of Ferring International Center S.A. 35
DENTAID, S.L. 36
Clinical Trial Overview of DENTAID, S.L. 36
Boehringer Ingelheim Auslandsbeteiligungs GmbH 37
Clinical Trial Overview of Boehringer Ingelheim Auslandsbeteiligungs GmbH 37
AstraZeneca PLC 38
Clinical Trial Overview of AstraZeneca PLC 38
Allergan, Inc. 39
Clinical Trial Overview of Allergan, Inc. 39
Aldeyra Therapeutics, Inc. 40
Clinical Trial Overview of Aldeyra Therapeutics, Inc. 40
Akorn, Inc. 41
Clinical Trial Overview of Akorn, Inc. 41
Clinical Trial Overview of Top Institutes / Government 42
National Institute of Dental and Craniofacial Research 42
Clinical Trial Overview of National Institute of Dental and Craniofacial Research 42
University Medical Center Groningen 43
Clinical Trial Overview of University Medical Center Groningen 43
National Institute of Arthritis and Musculoskeletal and Skin Diseases 44
Clinical Trial Overview of National Institute of Arthritis and Musculoskeletal and Skin Diseases 44
Assistance Publique - Hopitaux de Paris 45
Clinical Trial Overview of Assistance Publique - Hopitaux de Paris 45
UMC Utrecht Holding BV 46
Clinical Trial Overview of UMC Utrecht Holding BV 46
University of Sao Paulo 47
Clinical Trial Overview of University of Sao Paulo 47
The National Institute of Allergy and Infectious Diseases 48
Clinical Trial Overview of The National Institute of Allergy and Infectious Diseases 48
Chiba University 49
Clinical Trial Overview of Chiba University 49
Kanazawa Medical University 50
Clinical Trial Overview of Kanazawa Medical University 50
National Institute of Environmental Health Sciences 51
Clinical Trial Overview of National Institute of Environmental Health Sciences 51
Five Key Clinical Profiles 52
Appendix 74
Abbreviations 74
Definitions 74
Research Methodology 75
Secondary Research 75
About GlobalData 76
Contact Us 76
Disclaimer 76
Source 76

List of Tables

Sjogren's Syndrome Therapeutics, Global, Clinical Trials by Region, 2014* 7
Sjogren's Syndrome Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Sjogren's Syndrome Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Sjogren's Syndrome Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014* 10
Sjogren's Syndrome Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11
Sjogren's Syndrome Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
Sjogren's Syndrome Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014* 13
Sjogren's Syndrome Therapeutics Clinical Trials, Central and South America, Top Countries, 2014* 14
Proportion of Sjogren's Syndrome to Immunology Clinical Trials, G7 Countries (%), 2014* 15
Sjogren's Syndrome Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Sjogren's Syndrome Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Sjogren's Syndrome to Immunology Clinical Trials, E7 Countries (%), 2014* 18
Sjogren's Syndrome Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Sjogren's Syndrome Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Sjogren's Syndrome Therapeutics, Global, Clinical Trials by Phase, 2014* 21
Sjogren's Syndrome Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 22
Sjogren's Syndrome Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Sjogren's Syndrome Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Sjogren's Syndrome Therapeutics, Global, Withdrawn Clinical Trials, 2014* 25
Sjogren's Syndrome Therapeutics, Global, Terminated Clinical Trials, 2014* 26
Sjogren's Syndrome Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 27
Sjogren's Syndrome Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 28
Sjogren's Syndrome Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 29
Sjogren's Syndrome Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 30
Sjogren's Syndrome Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 31
Sjogren's Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2014* 32
Sjogren's Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Volution Immuno Pharmaceuticals (VIP) SA, 2014* 33
Sjogren's Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Parion Sciences, Inc., 2014* 34
Sjogren's Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Ferring International Center S.A., 2014* 35
Sjogren's Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by DENTAID, S.L., 2014* 36
Sjogren's Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Boehringer Ingelheim Auslandsbeteiligungs GmbH, 2014* 37
Sjogren's Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2014* 38
Sjogren's Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Allergan, Inc., 2014* 39
Sjogren's Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Aldeyra Therapeutics, Inc., 2014* 40
Sjogren's Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Akorn, Inc., 2014* 41
Sjogren's Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by National Institute of Dental and Craniofacial Research, 2014* 42
Sjogren's Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by University Medical Center Groningen, 2014* 43
Sjogren's Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by National Institute of Arthritis and Musculoskeletal and Skin Diseases, 2014* 44
Sjogren's Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Assistance Publique - Hopitaux de Paris, 2014* 45
Sjogren's Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by UMC Utrecht Holding BV, 2014* 46
Sjogren's Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Sao Paulo, 2014* 47
Sjogren's Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Allergy and Infectious Diseases, 2014* 48
Sjogren's Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Chiba University, 2014* 49
Sjogren's Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Kanazawa Medical University, 2014* 50
Sjogren's Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by National Institute of Environmental Health Sciences, 2014* 51

List of Figures

Sjogren's Syndrome Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
Sjogren's Syndrome Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Sjogren's Syndrome Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Sjogren's Syndrome Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014* 10
Sjogren's Syndrome Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 11
Sjogren's Syndrome Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12
Sjogren's Syndrome Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2014* 14
Proportion of Sjogren's Syndrome to Immunology Clinical Trials, G7 Countries (%), 2014* 15
Sjogren's Syndrome Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Sjogren's Syndrome Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Sjogren's Syndrome to Immunology Clinical Trials, E7 Countries (%), 2014* 18
Sjogren's Syndrome Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Sjogren's Syndrome Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Sjogren's Syndrome Therapeutics, Global, Clinical Trials by Phase (%), 2014* 21
Sjogren's Syndrome Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 22
Sjogren's Syndrome Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Sjogren's Syndrome Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Sjogren's Syndrome Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 27
Sjogren's Syndrome Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 28
Sjogren's Syndrome Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 29
Sjogren's Syndrome Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 30
Sjogren's Syndrome Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 31

Inquiry For Buying

Please fill your details below, to inquire about this report:
Indicates required fields

Request Sample

Please fill your details below, to receive sample report:
Indicates required fields

  • Payment Mode

COVID-19 Pandemic Impacts

Our Analysts and Consultants are working ceaselessly to congregate, identify, analyze, and portray the Actual Impacts of COVID-19 Global Pandemic in each of our published as well as ongoing research reports to Redefine and Revise Current and Future Market Trends, Growth Rates, And Market Size Projections across the Globe as well as in different Regions and individual Countries.

Single User | $(USD)2500 View Pricing